
Belfast-based GenoME Diagnostics secures over €1.5 million to improve cancer diagnosis
Published on March 6, 2023
GenoME Diagnostics has just secured over €1.5 million (£1.4 million) to develop its solution for earlier and more accurate detection of ovarian cancer. The Belfast-based team now plans to expand. Spotting cancer early is critical. It means that treatment can get underway before cancer spreads and can drastically increase the chance of survival. When it…
The post Belfast-based GenoME Diagnostics secures over €1.5 million to improve cancer diagnosis appeared first on EU-Startups.
